Oregon Health and Science University: Cognitive Dysfunction trials

The registry lists 13 Cognitive Dysfunction studies with Oregon Health and Science University as lead sponsor. 3 are open to participants now and 4 have results posted.

Early Phase 1 2Phase 1 3Phase 2 4Phase 3 1Phase 4 1No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Total Intravenous Versus Inhalational Anesthesia- A Geriatric Anesthesia StudyRecruitingNCT06036095Phase 4
• Safety and Target Engagement of Centella Asiatica in Cognitive ImpairmentRecruitingNCT05591027Phase 1
• OCT Angiography and NRAI in DementiaRecruitingNCT03761381
• Efficacy of a Multimodal Brain Health Intervention for Older African AmericansCompletedNCT04863378Not applicableResults posted
• Pharmacokinetics Centella Asiatica Product (CAP) in Mild Cognitive ImpairmentTerminatedNCT03937908Early Phase 1Results posted
• Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple SclerosisCompletedNCT02133664Phase 1/2Results posted
• Conversations as a Means to Delay the Onset of Alzheimer's DiseaseCompletedNCT01571427Early Phase 1Results posted
• Neighborhood-based Physical and Social Activity for Older Black Caregivers and People Living With DementiaCompletedNCT05658328Not applicable
• Protecting Alzheimer Caregivers Using Technology Through Staying SharpStatus unknownNCT05260515Phase 1/2
• Cohort Study of Risk Factors for Postoperative Cognitive DeclineCompletedNCT03676738
• Acute Care for Elders (ACE) Program at OHSU HospitalStatus unknownNCT02119078Not applicable
• n-3 PUFA for Vascular Cognitive AgingStatus unknownNCT01953705Phase 2
• Trial of Memantine for Cognitive Impairment in Multiple SclerosisCompletedNCT00300716Phase 2/3